Facebook Linkedin Twitter
Inside Precision Medicine Terns Pharmaceuticals’ Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Leukemia

Chronic myeloid leukemia cells or CML
News & Features

Terns Pharmaceuticals’ Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Chris Anderson
0
Acute myeloid leukemia (AML)
Molecular Dx

NIH Launches myeloMATCH Precision Medicine Trials for Myeloid Cancers

0
Lymphocytes and biomedical concept, 3d rendering.
News & Features

First Patient Dosed with In Vivo Gene Therapy for CAR T

Jonathan D. Grinstein, PhD
0
3d render of CAR T cells attacking and killing blood cancer cells
News & Features

On/Off Switch for CAR-T Cell Therapy Shows Early Promise

0
Destruction of leukaemia cell in blood cancer
Molecular Dx

Certain Pediatric Leukemia Subtypes Can Have Good Outcomes Even with Low-Intensity Therapy 

0
Mother throwing up her Son with Down Syndrome at home
News & Features

Reasons Behind Leukemia Susceptibility in People with Down Syndrome Uncovered

0
Acute myeloid leukemia (AML)
News & Features

MyeloMATCH Plans to Bring Precision Treatments to U.S. Blood Cancer Patients

0
TKI Acalabrutinib molecular structure isolated on white
News & Features

Adding Ruxolitinib to TKI Treatments Enhances Molecular Response in Chronic Myeloid Leukemia

0
prostate cancer cells, SEM. CRPC
News & Features

New Prostate Cancer Treatment Shows Promise in Preclinical Studies

0
Cancer Gene
News & Features

New DNA-Targeting Screening Technique for Cancer Therapies

0
123...17Page 1 of 17

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine